Healthcare

In 1H17, Teva Pharmaceutical’s (TEVA) oncology business generated revenues of ~$550 million, or ~9% lower YoY (year-over-year).

In 4Q17, Merck’s (MRK) Cubicin reported revenues of $92 million, which was ~23% lower on a YoY (year-over-year) basis.

Pfizer (PFE) released its 1Q18 earnings today, reporting another strong quarter for the Innovative health business.

Today, Biogen (BIIB) and partner Eisai presented highly anticipated detailed study data for their investigational Alzheimer’s drug BAN2401.

In its 2Q17 earnings conference call, Edwards Lifesciences (EW) projected 2017 adjusted EPS to fall to $3.65–$3.85, which is higher than the previous $3.43–$3.55.

Domestic moat companies, as represented by the Morningstar® Wide Moat Focus IndexSM (MWMFTR, or “U.S. Moat Index”), once again posted strong results in July.

On Nov. 9, Pfizer announced that its coronavirus vaccine is more than 90 percent effective. Who owns Pfizer and where is the company based?

In Amazon's latest push into healthcare, the company has launched Amazon Pharmacy. Will Amazon disrupt the pharmacy industry?

McKesson stock has soared as the pandemic has created a business boom for the company. Will vaccines reverse the gains?

The Pfizer-BioNTech vaccine holds life-changing potential. Who are the owners that are running the show?

Moderna, a biopharmaceutical company, has a coronavirus vaccine with initial trial results that show 94.5 percent effectiveness.

Peloton stock has been under pressure amid positive news about COVID-19 vaccine candidates. Should you buy PTON stock after the recent crash?

AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group. Is AstraZeneca a good stock to buy?

Cannabis stocks have been in a freefall over the last two years. What are the top marijuana penny stocks in 2020?

College students may qualify for Medicaid depending on the state they live in and their family income level.

TalkSpace Teletherapy App Prepares to Go Public in Next Six Months With $1 Billion Valuation

Finding affordable health insurance can be a difficult prospect, especially if you or your loved ones have an underlying health condition. However, there are affordable options out there.

Plasma stocks popped up after the FDA cleared hospitals to use plasma-derived therapy to treat COVID-19 patients.

Albert Bourla, CEO of pharmaceutical giant Pfizer, has said there is a 60 percent chance that the company's scientists will know whether their vaccine is effective by the end of October.

The U.S. government’s Operation Warp Speed program has already invested billions in six potential coronavirus vaccine candidates.

Is Obamacare still in effect? The Affordable Care Act is still law, but its constitutionality depends on an upcoming Supreme Court decision.

Today, biotechnology company Moderna announced its collaboration with Catalent for large-scale manufacturing of its potential COVID-19 vaccine.

Amarin stock dropped 31 percent yesterday in response to the company’s Vascepa appeal hearing.

Since 2010, SAP AG (SAP) spent more than ~$12 billion on acquisitions. Concur Technologies is the largest acquisition in SAP’s 42-year history. In its 2Q14 results, most of SAP’s growth was from its cloud business—approximately $1 billion annually. Concur’s management mentioned that they expect to end fiscal year 2014 with ~$690 million.

Monday could prove to be a good day for the markets after positive news about coronavirus treatments and vaccines.

Roche Holding has agreed to help develop and distribute an experimental COVID-19 drug in partnership with Regeneron Pharmaceuticals.

Bausch Health’s (BHC) net revenues declined from $4.3 billion in H1 2017 to $4.1 billion in H1 2018, reflecting an ~5.0% year-over-year decline.

Abbott Laboratories (ABT) is a brand new position that accounts for 1.19% of Chilton’s fourth quarter 2013 portfolio.

Myriad Genetics (MYGN) expects to report revenues in the range of $750 million–$770 million in fiscal 2018 (ended June 30, 2018).

In 2018, the global pharmaceutical industry stood at $1.2 trillion, and experts expect $1.5 trillion by 2023. Here’s everything investors need to know.

Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.

Cannabis stocks have underperformed the broader markets. Despite the underperformance, Aphria’s recent financial performance was impressive.

On October 18, CNBC reported Bill Gross top picks. His top stock picks were Annaly Capital (NLY), Invesco (IVZ) and Allergan (AGN).

You can break down average hospital costs into salary expenses, supply expenses, bad debt expenses, and miscellaneous expenses. Labor costs account for about 49% of expenses, and they’re the biggest expenses for hospitals.

CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.

What is a Sharpe ratio? A Sharpe ratio is a tool that measures the amount of returns for each unit of volatility that’s generated by a portfolio (higher returns and lower volatility equals more returns per unit of volatility). The measurement allows investors to analyze how much return they’re receiving from a portfolio in exchange for […]

Capital projects in the hospital sector include purchasing new facilities, purchasing medical equipment, renovating and replacing existing hospitals, and investing in information systems infrastructure.

Apple (AAPL) is one of the most cash-rich companies in the US. While Carl Icahn has been talking about share buybacks artificially inflating the Market and asset values, some buybacks have occurred as a result of his push.

Target had upbeat revenue performance in fiscal 4Q16 and 2016. Store traffic was up by 1.3% YoY in fiscal 2016, trending in positive territory in all four quarters of the year.

Target has identified four signature categories it’s concentrating on to provide higher store and web traffic and sales: Baby, Style, Wellness, and Kids.